Latitude Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ECSS
ATO
Latitude Advisors's ABBV Position: Q2 2026 in Review
Latitude Advisors increased its AbbVie (ABBV) stake by 2.2% in Q2 2026, buying an estimated $60.5K and bringing the position to 13,295 shares worth $3.35M. The position accounts for 1.33% of the portfolio, ranked #14.
Latitude Advisors first reported a position in ABBV in Q3 2021 and has held it in 20 quarters since. 1,993 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Latitude Advisors held 13,295 shares of AbbVie worth $3.35M as of Q2 2026.
- Latitude Advisors bought 281 AbbVie shares in Q2 2026, an estimated $60.5K.
- AbbVie made up 1.33% of Latitude Advisors's portfolio in Q2 2026, its #14 holding.
- Latitude Advisors first reported a position in AbbVie in Q3 2021 and has held it in 20 quarters since.
- 1,993 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Latitude Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.